Novara Mark David 4
4 · TANDEM DIABETES CARE INC · Filed Sep 16, 2025
Insider Transaction Report
Form 4
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-09-15−7,415→ 37,073 total→ Common Stock (7,415 underlying) - Exercise/Conversion
Common Stock
2025-09-15+7,415→ 36,214 total - Tax Payment
Common Stock
2025-09-15$12.09/sh−3,866$46,740→ 32,348 total
Footnotes (4)
- [F1]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.